The principles and feasibility of disease eradication

Vaccine

Volumn 29, Issue SUPPL. 4, 2011, Pages

  Dowdle, Walter R ^a   Cochi, Stephen L ^b  

^a Task Force for Global Health   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Disease; Eradication; Global

Indexed keywords

ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; COST BENEFIT ANALYSIS; DISEASE CONTROL; DRACUNCULIASIS; FEASIBILITY STUDY; FUNDING; HEALTH CARE COST; HUMAN; MEASLES; MEDICAL DECISION MAKING; NONHUMAN; OUTCOME ASSESSMENT; POLIOMYELITIS; POLITICS; PRIORITY JOURNAL; RUBELLA; SMALLPOX; VACCINATION;

COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; DRACUNCULIASIS; HUMANS; MEASLES; POLIOMYELITIS; RUBELLA; WORLD HEALTH;

EID: 84859480082     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.006     Document Type: Article

References (27)

1. Henderson D.A. Principles and lessons from the smallpox eradication programme. Bull World Health Organ 1987, 65:535-546.
2. Dowdle W.R. Perspectives for elimination/eradication of diseases with vaccines. Vaccines: preventing disease and protecting health 2004, 354-360. Pan American Health Organization, Washington, DC. C.A. de Quadros (Ed.).
3. The oxford dictionary and thesaurus (American edition) 1996, Oxford University Press, New York.
4. Soper F.L. Problems to be solved if the eradication of tuberculosis is to be realized. Am J Public Health 1962, 52:734-745.
5. Andrews J.M., Langmuir A.D. The philosophy of disease eradication. Am J Public Health 1963, 53:1-6.
6. Hinman A.R. Prospects for disease eradication or elimination. N Y State J Med 1984, 84:502-506.
7. CDC (Centers for Disease Control and Prevention) Recommendations of the International Task Force for Disease Eradication. MMWR 1993, 42:1-38.
8. Ottesen E.A., Dowdle W.R., Fenner F., Habermehl K.-O., John T.J., Koch M.A., et al. Group report: how is eradication to be defined and what are the biological criteria?. The eradication of infectious diseases 1998, 47-59. John Wiley & Sons, Chichester, UK. W.R. Dowdle, D.R. Hopkins (Eds.).
9. Post-conference small group report. Bull World Health Organ 1998, 76:113.
10. Cello J., Paul A.V., Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 2002, 297:1016-1018.
11. Singer P.A., Daar A.S. How biodevelopment can enhance biosecurity. Bull Atomic Scientists 2009, 65:22-30.
12. WHO (World Health Organization) Monitoring progress towards measles elimination. Wkly Epidemiol Rec 2010, 85:490-495.
13. WHO (World Health Organization) Elimination of Yaws in India. Wkly Epidemiol Rec 2008, 83:125-132.
14. Thompson K.M., Duintjer Tebbens R.J. Eradication versus control for poliomyelitis: an economic analysis. Lancet 2007, 369:1363-1371.
15. Duintjer Tebbens R.J., Pallansch M.A., Cochi S.L., Wassilak S.G.F., Linkins J., Sutter R.W., et al. Economic analysis of the global polio initiative. Vaccine 2011, 29:334-343.
16. WHO (World Health Organization) Outbreaks following importations of wild poliovirus into countries of WHO African, European, and South-East Asian regions: January 2009-September 2010. Wkly Epidemiol Rec 2010, 85:445-452.
17. Barrett S. Eradication versus control: the economics of global infectious disease policies. Bull World Health Organ 2004, 82:683-688.
18. The eradication of infectious diseases 1998, John Wiley & Sons, Chichester, UK. W.R. Dowdle, D.R. Hopkins (Eds.).
19. WHO (World Health Organization) Global disease elimination and eradication as public health strategies. Bull World Health Organ 1998, 76(Suppl. 2):1-162.
20. Aylward A., Hennesssey K.A., Zagaria N., Olive J.M., Cochi S. When is a disease eradicable? 100 years of lessons learned. Am J Public Health 2000, 90:1515-1520.
21. Hinman A.R., Hopkins D.R. Lessons from previous eradication programs. The eradication of infectious diseases 1998, 19-31. John Wiley & Sons, Chichester, UK. W.R. Dowdle, D.R. Hopkins (Eds.).
22. Roeder P.L. The animal story. BMJ 2005, 331:1262-1263.
23. Polio Research Committee: conclusions and recommendations. The Polio Pipeline 2010;5:1-5. mailto:polioresearch@who.int.
24. Obregon R., Chitnis K., Morry C., Feek W., Bates J., Galway M., et al. Achieving polio eradication: a review of health communications evidence and lessons learned in India and Pakistan. Bull World Health Organ 2009, 87:624-630.
25. Sutter R.W., John T.J., Agarkhedkar S., Ramanan P.V., Verma H., Deshpande J., et al. Immunogenicity of bivalent types 1 and 3 poliovirus vaccine: a randomized, double-blind, controlled trial. Lancet 2010, 376:1-7.
26. Thompson K.M., Duintjer Tebbens R.J., Pallansch M.A. Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Analysis 2006, 26:1541-1556.
27. Hopkins DR. The allure of eradication. In: Global Health Magazine 2009;3:14-7. http://www.globalhealthmagazine.com/.